Kalvista Pharmaceuticals Inc (NASDAQ:KALV) Insider Trading Activity – Major Shareholder Sold 43,378 shares of Stock

ME Staff

6 years ago

Insider Trading Activity For Kalvista Pharmaceuticals Inc (NASDAQ:KALV)

Svlsf Iv, Llc , Major Shareholder of Kalvista Pharmaceuticals Inc (NASDAQ:KALV) reportedly Sold 43,378 shares of the company’s stock at an average price of 22.91 for a total transaction amount of $993,789.98 SEC Form

Insider Trading History For Kalvista Pharmaceuticals Inc (NASDAQ:KALV)

On 4/14/2015 Albert Cha, Director, bought 1,012,500 with an average share price of $5.00 per share and the total transaction amounting to $5,062,500.00.

On 4/14/2015 Acmp Iv Llc, Major Shareholder, bought 877,500 with an average share price of $5.00 per share and the total transaction amounting to $4,387,500.00.

On 12/30/2015 David Renzi, CEO, sold 10,000 with an average share price of $3.70 per share and the total transaction amounting to $37,000.00.

On 9/13/2017 Holdings A/S Novo, Major Shareholder, sold 25,900 with an average share price of $8.02 per share and the total transaction amounting to $207,718.00.

On 9/14/2017 Holdings A/S Novo, Major Shareholder, sold 10,000 with an average share price of $8.05 per share and the total transaction amounting to $80,500.00.

On 9/15/2017 Holdings A/S Novo, Major Shareholder, sold 176,647 with an average share price of $7.21 per share and the total transaction amounting to $1,273,624.87.

On 10/12/2017 Rajeev M Shah, Director, bought 850,000 with an average share price of $8.50 per share and the total transaction amounting to $7,225,000.00.

Analyst Ratings History For Kalvista Pharmaceuticals Inc (NASDAQ:KALV)

On 4/29/2018 BTIG Research Reiterated Rating Buy
On 7/10/2018 Roth Capital Initiated Coverage of rating Buy with a price target of $20.00
On 10/15/2018 Stifel Nicolaus Initiated Coverage of rating Buy
On 10/30/2018 Jefferies Financial Group Initiated Coverage of rating Buy to Buy with a price target of $30.00
On 12/14/2018 Cantor Fitzgerald Reiterated Rating Buy with a price target of $32.00

Recent Trading Activity for Kalvista Pharmaceuticals Inc (NASDAQ:KALV)
Shares of Kalvista Pharmaceuticals Inc closed the previous trading session at with 22.76 shares trading hands.